Comparative Evaluation of CTG With and Without rhPDGF- BB Using Modified Coronally Advanced Tunnel for Root Coverage
- Conditions
- Gingival Recession
- Registration Number
- NCT03676088
- Lead Sponsor
- Krishnadevaraya College of Dental Sciences & Hospital
- Brief Summary
The present study is a human, prospective, single centre, single blind, comparative controlled randomized clinical trial for the treatment of Miller's Class I, II or combination of class I and II mandibular recession and comparing the clinical outcomes prior to and 6 months after treatment. The trial is in accordance to the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.
- Detailed Description
24 recession defects were selected in patients who were systemically and periodontally healthy, satisfying the determined inclusion criteria. Patients with at least two or more teeth having Miller's class I , II or combination of class I and II mandibular recession defects were included in the study. A detailed, thorough medical and dental history was obtained and each patient was subjected to comprehensive clinical and radiological examination. All patients were informed about the nature of the study, surgical procedure involved, potential benefits and risks associated with the surgical procedure and a written informed consent was obtained from all patients.
The patients were assigned into two treatment groups (test and control). The test group was treated with recombinant human Platelet Derived Growth Factor-BB and Modified Coronally Advanced Tunnel +Connective Tissue Graft whereas the control group was treated by Modified Coronally Advanced Tunnel +Connective Tissue Graft alone.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6
-
Patients fulfilling the following criteria were included in the study:-
- Two or more teeth with Miller's class I and II or combined class I and II recession defects in mandibular anteriors.
- Age group 21-58 years.
- Patients with healthy or treated periodontal conditions.
- Patients willing to participate in the study.
- Absence of uncontrolled medical conditions.
- Patients with full mouth plaque score </= 10%(O'Leary 1972)
- Patients with esthetic concerns.
- Patients with thick gingival biotype >0.8mm
- Pregnant or lactating females.
- Tobacco smoking.
- Uncontrolled medical conditions.
- Untreated periodontal conditions.
- Use of systemic antibiotics in the past 3 months.
- Patients treated with any medication known to cause gingival hyperplasia.
- Drug and alcohol abuse
- No occlusal interferences.
- Patient with a known hypersensitivity to rhPDGF-BB.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Gingival recession depth (GRD) 6 months measured as the distance from the Cemento Enamel Junction to the gingival margin
2. Gingival Recession Width (GRW) 6 months measured as the distance between the mesial gingival margin and distal gingival margin
Mean root coverage(MRC) 6 months (Baseline recession depth - 6 month recession depth/Baseline recession depth)\*100
Complete root coverage(CRC) 6 months root coverage regarded as complete with gingival margin located at the level of Cemento Enamel Junction
coverage esthetic score(RCES) 6 months The Aesthetic evaluation was performed according to the root coverage aesthetic score system (RES)
Five Variables evaluated which are as follows:
1. Level of Gingival margin (GM)
2. Marginal Tissue Contour (MTC)
3. Soft Tissue Texture (STT)
4. Mucogingival Junction(MJ) alignment
5. Gingival Colour (GC)
- Secondary Outcome Measures
Name Time Method probing pocket depth (PD) 6 months measured as the distance from the gingival margin to the base of gingival sulcus
clinical attachment level (CAL) 6 months measured as Gingival Recession Depth + Probing Depth
width of keratinized tissue (KTW) 6 months measured as the distance from the mucogingival junction to the gingival margin , with the mucogingival junction location determined using a visual method (Schiller's Potassium Iodide Solution).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.